Log In
BCIQ
Print this Print this
 

TKM-ALDH2

  Manage Alerts
Collapse Summary General Information
Company Arbutus Biopharma Corp.
DescriptionShort interfering RNA (siRNA) targeting aldehyde dehydrogenase 2 family mitochondrial (ALDH2) formulated using lipid nanoparticle delivery technology
Molecular Target Aldehyde dehydrogenase 2 family mitochondrial (ALDH2)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: siRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationAddiction
Indication DetailsTreat alcohol dependence
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today